Publications of H. Daub
All genres
Journal Article (29)
21.
Journal Article
6 (3), pp. 537 - 547 (2007)
Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Molecular & Cellular Proteomics 22.
Journal Article
5 (10 Suppl. Suppl. S), p. S168 - S168 (2006)
Quantitative analysis of receptor tyrosine kinase signaling exploited by Listeria monocytogenes. Molecular & Cellular Proteomics 23.
Journal Article
1 (1), pp. 67 - 95 (2006)
Signal transduction therapy with rationally designed kinase inhibitors. Current Signal Transduction Therapy 24.
Journal Article
1754 (1-2), pp. 183 - 190 (2005)
Characterisation of kinase-selective inhibitors by chemical proteomics. Biochimica et Biophysica Acta-Proteins and Proteomics 25.
Journal Article
65 (15), pp. 6919 - 6926 (2005)
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling. Cancer Research 26.
Journal Article
3 (12), pp. 1001 - 1010 (2004)
Strategies to overcome resistance to targeted protein kinase inhibitors. Nature Reviews Drug Discovery 27.
Journal Article
11 (5), pp. 691 - 701 (2004)
Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors. Chemistry & Biology 28.
Journal Article
278 (17), pp. 15435 - 15440 (2003)
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. Journal of Biological Chemistry 29.
Journal Article
76 (16), pp. 8124 - 8137 (2002)
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. Journal of Virology Meeting Abstract (1)
30.
Meeting Abstract
120 (21), 786. 54th Annual Meeting and Exposition of the American-Society-of-Hematology
(ASH), Atlanta, GA, December 08, 2012 - December 11, 2012. AMER SOC HEMATOLOGY, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA (2012)
Global Phosphoproteome Analysis of AML Bone Marrow Reveals Predictive Markers for the Treatment with AC220. In BLOOD, Thesis - Habilitation (1)
31.
Thesis - Habilitation
Analysis of protein kinases by chemical proteomics. Habilitation, Technische Universität, München (2010)